4-Methylpyrimidine-5-carboxamide

Catalog No.: 
ACDSHX793
CAS No.: 
1852179-59-9
Molecular Formula: 
C6H7N3O
Molecular Weight: 
137.14
4-Methylpyrimidine-5-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$97.00InquiryInquiry
250mg97%$165.00InquiryInquiry
1g97%$443.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methylpyrimidine-5-carboxamide
IUPAC Name4-methylpyrimidine-5-carboxamide
Molecular FormulaC6H7N3O
Molecular Weight137.14
SMILESO=C(C1=CN=CN=C1C)N
InChI KeyIYDHZQGNHVNQIJ-UHFFFAOYSA-N
Synonym5-Pyrimidinecarboxamide, 4-methyl-;4-methyl-5-pyrimidinecarboxamide;4-Methylpyrimidine-5-Carboxamide
CAS No.1852179-59-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDSHX793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQOMT184 route compound structure diagram
    ACQOMT184157335-92-7In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACDSHX793 route product structure diagram
    ACDSHX7931852179-59-9
Inquiry

2. ACDSHX793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACDSHX793 route product structure diagram
    ACDSHX7931852179-59-9
Inquiry

3. ACDSHX793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLWXC497 route compound structure diagram
    ACLWXC497110960-73-1In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACDSHX793 route product structure diagram
    ACDSHX7931852179-59-9
Inquiry

Comments (0)